BAVIS_1170x120_1-20

COVID-19 vaccine

HDA releases policy principles for COVID-19 vaccine distribution

HDA releases policy principles for COVID-19 vaccine distribution

ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) today released policy principles reaffirming the pharmaceutical distribution industry’s commitment to ensuring — in partnership with federal and state governments — the safe and efficient distribution of COVID-19 vaccines once they are approved by the Food and Drug Administration. HDA highlights four priority areas for vaccine distribution:

Vaccine makers will not be rushed

Vaccine makers will not be rushed

NEW YORK — The effort to develop a safe and effective vaccine for COVID-19 has been an all-hands-on-deck approach ever since the virus began wreaking havoc across the globe earlier this year. But it seems now, with the presidential election less than two months away — and with President Trump promising a vaccine “very soon”

HHS: Pharmacists can administer COVID-19 vaccine

HHS: Pharmacists can administer COVID-19 vaccine

WASHINGTON — The Department of Health and Human Services (HHS) this month authorized pharmacists to order and administer COVID-19 vaccination, a move welcomed by pharmacy advocates. “This is an extremely important decision by the administration,” said National Association of Chain Drug Stores president and chief executive officer Steve Anderson. “When safe and effective COVID-19 vaccinations

NACDS welcomes HHS decision to empower pharmacists to administer COVID-19 vaccinations

NACDS welcomes HHS decision to empower pharmacists to administer COVID-19 vaccinations

ARLINGTON, Va. — NACDS president and CEO Steven Anderson issued a statement Thursday upon the U.S. Department of Health and Human Services (HHS) issuanceof guidance under the Public Readiness and Emergency Preparedness Act (PREP Act) to expand access to safe and effective COVID-19 vaccines when they are made available. This guidance authorizes state-licensed pharmacists to

APhA hails HHS announcement authorizing pharmacists to administer COVID-19 vaccines

APhA hails HHS announcement authorizing pharmacists to administer COVID-19 vaccines

WASHINGTON — The U.S. Department of Health and Human Services (HHS) authorized pharmacists and pharmacist interns to order and administer COVID-19 vaccines that have been approved or licensed by the Food and Drug Administration (FDA) to all individuals age 3 or older. Pharmacist interns must do so while acting under the supervision of qualified pharmacist.

Moderna announces COVID-19 vaccine deal

Moderna announces COVID-19 vaccine deal

CAMBRIDGE, Mass.— Moderna announced that the U.S. government has secured 100 million doses of mRNA-1273 as part of the U.S. government’s goal of securing early access to safe and effective COVID-19 vaccines for the American people. The award of up to $1.525 billion is for the manufacturing and delivery of 100 million doses of mRNA-1273

NIH launches clinical trails network to test COVID-19 vaccines, other tools

NIH launches clinical trails network to test COVID-19 vaccines, other tools

WASHINGTON — The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has established a new clinical trials network that aims to enroll thousands of volunteers in large-scale clinical trials testing a variety of investigational vaccines and monoclonal antibodies intended to protect people from COVID-19. The COVID-19 Prevention Trials

GSK to produce 1 billion doses of pandemic vaccine adjuvant in 2021 to support multiple COVID-19 vaccine collaborations

GSK to produce 1 billion doses of pandemic vaccine adjuvant in 2021 to support multiple COVID-19 vaccine collaborations

LONDON — GSK has confirmed its intention to manufacture 1 billion doses of its pandemic vaccine adjuvant system, in 2021, to support the development of multiple adjuvanted COVID-19 vaccine candidates. GSK believes that its pandemic adjuvant technology could make a significant contribution against COVID-19.  As demonstrated in the last flu pandemic, GSK’s pandemic adjuvant can

AstraZeneca advances response to global COVID-19 challenge as it gets commitment for Oxford’s potential new vaccine

AstraZeneca advances response to global COVID-19 challenge as it gets commitment for Oxford’s potential new vaccine

CAMBRIDGE, U.K. — AstraZeneca is advancing its ongoing response to address the unprecedented challenges of COVID-19, collaborating with a number of countries and multilateral organizations to make the University of Oxford’s vaccine widely accessible around the world in an equitable manner. The company has concluded the first agreements for at least 400 million doses and

Pfizer and BioNTech dose first participants in the U.S. as part of global COVID-19 mRNA vaccine development program

Pfizer and BioNTech dose first participants in the U.S. as part of global COVID-19 mRNA vaccine development program

NEW YORK — Pfizer and BioNTech SE  announced Tuesday that the first participants have been dosed in the U.S. in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. The trial is part of a global development program, and the dosing of the first cohort in Germany was completed last week.

NIH mobilizes national innovation initiative for COVD-19 diagnostics

NIH mobilizes national innovation initiative for COVD-19 diagnostics

BETHESDA, Md. — The National Institutes of Health (NIH) announced Wednesday a new initiative aimed at speeding innovation, development and commercialization of COVID-19 testing technologies, a pivotal component needed to return to normal during this unprecedented global pandemic. With a $1.5 billion investment from federal stimulus funding, the newly launched Rapid Acceleration of Diagnostics (RADx)